MAY 29, 2018 07:30 AM PDT

Early Research Makes Connection Between Liver Tumor Growth Control and Gut Microbiota

As researchers learn more about the gut microbiome, they have focused attention on the interactions between the individual bacteria, the body, and immunity.  Researchers recently published work in Science sharing findings of a connection between the gut microbiome and liver tumor growth.

The gut microbiome, or gut microbiota, describes the diverse environment of microorganisms in the human and animal digestive tract.  Many studies have looked at the connections between the gut microbiome and human health and disease.  Its role is critical for human metabolism and affects nutrition, physiology and immune function.  It is widely accepted that there are hundreds of different species of bacteria that can make up an individual’s gut microbiota; in fact, at least a third are shared amongst a majority of people with the other two thirds being unique to each individual.  Our individual gut microbiome is like a fingerprint on the inside.

The murine study published in Science focused on the effects of antibiotics and gut microbiota in the presence of liver tumors.  The group used three different liver cancer types and reduced gastrointestinal bacteria with a combination of antibiotics.  The researchers found that by treating mice with liver tumors with antibiotics, they decreased particular bacteria and in turn, changed the make-up of immune cells in the liver.  The decreased number of bacteria induced an increase in natural killer T-cells which actually shrunk the liver tumors and acted as tumor suppressors.  In exploring this finding, the researchers determined that the accumulation of natural killer cells in the liver occurred due to increased expression of CXCL16, a protein found on the lining cells of liver capillaries.  In examining the role of CXCL16, the protein expression patterns were regulated by bile acids.  Increasing bile acids in mice changed the number of natural killer cells found in the liver and, therefore, could decrease the number of tumors in the liver.

The last connection made in this publication was that one specific bacterial species in the mouse microbiome controls metabolism of bile acids.  Clostridium scindens moderates CXCL16 expression, affects natural killer cell presence, and tumor cell growth within the environment of the liver.

The authors recognize that these results are just the beginning but lay the groundwork for future discoveries connecting the gut microbiome to key processes in our bodies that are, as of yet, unknown.

Sources: Science, National Cancer Institute, Gut Microbiota for Health,

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
JUN 19, 2018
Cancer
JUN 19, 2018
Malignant Glioma Growth Patterns Leave Hippocampus Unaffected
Malignant glioma has specific invasive patterns of growth within the brain; one structure avoided by tumor cells is the hippocampus....
JUL 04, 2018
Drug Discovery
JUL 04, 2018
Identifying New Drug Targets in Therapy-Resistant Cancers
Recent research published in the Nature Partner journal Systems Biology and Applications examines how genome-wide data used in collaboration with systems b...
JUL 10, 2018
Cancer
JUL 10, 2018
Risk Allele Variant SNP at 14q11.2 Linked to ALL
Researchers utilized genome-wide association studies to identify a variant SNP within a gene at 14q11.2 which is linked to ALL....
AUG 07, 2018
Cancer
AUG 07, 2018
Is There a Best Time of Day to Administer Chemo?
A common hematologic cancer chemotherapy agent is looked at for its efficacy on solid tumors and specifically evaluates if delivery time during the day affects is anti-tumor activity....
AUG 07, 2018
Cancer
AUG 07, 2018
Potential Bcl-2 Targeted Therapy for Relapsed Multiple Myeloma Patients
Targeted therapy for Bcl-2 may be helpful in more than the two lymphoma diagnoses that were recently approved by the FDA....
OCT 06, 2018
Genetics & Genomics
OCT 06, 2018
Genetic Mutation Linked to Increased Pancreatic Cancer Risk in Women
In a first, researchers have found a genetic mutation that has a sex-specific effect on pancreatic cancer risk....
Loading Comments...